small molecule

AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE

AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyAmneal Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameAMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
Active ingredientAMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
StrengthEQ 5MG BASE;20MG
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
FDA approvalDecember 2018
Marketing statusDISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.